• LinkedIn
SFL Regulatory Affairs & Scientific Communication Ltd.
  • About SFL
    • Why SFL
    • Team
    • Associations
    • History
    • Awards
    • Ethics
  • Services
    • Regulatory Affairs
    • Quality Assurance & GxP Compliance
    • Medical Affairs & Communication
    • Market Access & Reimbursement
    • Public Affairs & Regulatory Intelligence
    • Medical Devices, Combination Products and IVDs
    • Pharmacovigilance & Clinical Safety
    • Supply Chains of Medicines and Devices
    • Legal & Healthcare Compliance
    • Swiss Support
    • UK Support
    • Clinical Trials support
  • Clients
    • Testimonials
    • Cases
  • Trainings
    • Customized training
    • Webinars
  • News
    • News
    • Newsletter
  • Careers
  • Contact
  • Search
  • Menu Menu

SFL participating in BIO International Convention

SFL’s CEO, Shayesteh Fürst-Ladani, and SFL Pharma’s General Manager, François Bersier, will participate in the 2018 BIO International Convention, taking place in Boston, USA, on 4-7 June 2018. This year, BIO will celebrate its 25th anniversary with a program covering the latest developments in the biotechnology and pharmaceutical industries. Key topics that are also covered by SFL’s longstanding experience will include gene therapy, precision medicines, digital health, regulatory innovation and patient access.

In addition, SFL Pharma provides full support to pharma companies, who do not have a registered subsidiary in Switzerland, by acting as their Marketing Authorization Holder (MAH). Please get in touch with us to arrange a meeting with Shayesteh or François during the BIO International Convention.

  • News
  • Newsletter

Switzerland – Main Office

SFL Regulatory Affairs & Scientific Communication GmbH
Aeschenvorstadt 52 | CH-4051 Basel
Email: office@sfl-services.com
Phone: +41 61 361 9443

© Copyright 2023 - SFL Regulatory Affairs & Scientific Communication GmbH | Terms and Conditions | Privacy Statement | Cookies Policy
Scroll to top